D. Prime

发表

In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™)

R. Leggett, M. Hamilton, Cheng Pang, 2015, Journal of aerosol medicine and pulmonary drug delivery.

Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers.

G. P. Martin, H. Larhrib, C. Marriott, 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler

W. De Backer, D. Kelleher, A. Preece, 2015, Journal of aerosol medicine and pulmonary drug delivery.

Effect of Variable Inspiratory Flow Rate on the Performance of the Budesonide Rhinocort Turbuhaler™

J. Devalia, D. Prime, D. Richards, 2001, Clinical drug investigation.

iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes

B. Forbes, C. Ehrhardt, A. Hickey, 2022, Molecular pharmaceutics.

iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System

B. Forbes, C. Ehrhardt, A. Hickey, 2022, Molecular pharmaceutics.

Comparison Of Inhalation Profiles Through A Novel Dry Powder Inhaler (nDPI) And Lung Function Measurements For Healthy Subjects, Asthma And Chronic Obstructive Pulmonary Disease (COPD) Patients

D. Kelleher, A. Preece, W. Backer, 2012, ATS 2012.

Co-deposition of salmeterol and fluticasone propionate by a combination inhaler.

Brandon Whitcher, Alison Moore, Henry Chrystyn, 2006, International journal of pharmaceutics.

Drug Delivery to the Lungs 26, 2015 – N Stevens et al. How Particle Size Changes Lung Deposition: A Physical Modeller’s Perspective

D. Prime, N. Stevens, 2015 .

A critical comparison of the dose delivery characteristics of four alternative inhalation devices delivering salbutamol: pressurized metered dose inhaler, Diskus inhaler, Diskhaler inhaler, and Turbuhaler inhaler.

R. Woodhouse, A. L. Slater, A. C. Grant, 1999, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

Using polar ion-pairs to control drug delivery to the airways of the lungs.

D. Barlow, B. Forbes, A. Woods, 2020, Molecular pharmaceutics.

The influence of carrier and drug morphology on drug delivery from dry powder formulations.

Christopher Marriott, G. P. Martin, H. Larhrib, 2003, International journal of pharmaceutics.

In Vitro Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder Inhaler

R. Dhand, E. Taylor, M. Hamilton, 2023, Journal of aerosol medicine and pulmonary drug delivery.

Studies of the human oropharyngeal airspaces using magnetic resonance imaging IV--the oropharyngeal retention effect for four inhalation delivery systems.

Ian Shrubb, Bo Olsson, L. Borgström, 2007, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

Accuracy assessments for laser diffraction measurements of pharmaceutical lactose

John S. Shrimpton, J. Shrimpton, Mark Palmer, 2007 .

Analysis of polycyclic aromatic hydrocarbons in metered dose inhaler drug formulations by isotope dilution gas chromatography/mass spectrometry.

S. Sethi, D. Norwood, D. Prime, 1995, Journal of pharmaceutical and biomedical analysis.

Experimental observations of dry powder inhaler dose fluidisation.

J. Shrimpton, Matthew D. Jones, R. Price, 2008, International journal of pharmaceutics.

Development of an in vitro model to assess deposition of aerosol particles in a representative replica of the rat's respiratory tract.

P. Högger, D. Prime, P. Burnell, 2012, Journal of aerosol medicine and pulmonary drug delivery.

Latest advances in the development of dry powder inhalers.

Sumby, Prime, Ashurst, 2000, Pharmaceutical science & technology today.

In vitro investigation on the impact of airway mucus on drug dissolution and absorption at the air-epithelium interface in the lungs.

S. Stolnik, C. Bosquillon, Robyn C Sadler, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Detection and assessment of co-association in inhalable drug particles using aerosol time-of-flight mass spectrometry.

S. Zomer, D. Elder, E. Freney, 2008, Rapid communications in mass spectrometry : RCM.